1921
Volume 75, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.75.1025
2006-12-01
2017-11-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/75/6/0751025.html?itemId=/content/journals/10.4269/ajtmh.2006.75.1025&mimeType=html&fmt=ahah

References

  1. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH, 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320 : 545–550.
  2. Yan B-S, Kirby A, Shebzukhov YV, Daly MJ, Kramnik I, 2006. Genetic architecture of tuberculosis resistance in a mouse model of infection. Genes Immun 7 : 201–210.
  3. Woldehanna S, Volmink J, 2004. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Systematic Rev; 1 : CD000171.pub2.
  4. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, Sierra MF, Schoolnik GK, 1993. Exogenous reinfection with multidrug resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 328 : 1137–1144.
  5. Dube MP, Torriani FJ, See D, Havlir DV, Kemper CA, Leedom JM, Tilles JG, McCutchan JA, Sattler FR, 1999. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. Clin Infect Dis 28 : 136–138.
  6. Kawai V, Soto G, Gilman RH, Bautista CT, Caviedes L, Huaroto L, Ticona E, Ortiz J, Tovar M, Chavez V, Rodriguez R, Escombe AR, Evans CA, 2006. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg 75 : 1027–1033.
  7. Moore DAJ, Mendoza D, Gilman RH, Evans CAW, Delgado MGH, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, Soto G, Serpa J, The Tuberculosis Working Group in Peru, 2004. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Micro 42 : 4432–4437.
  8. Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V, 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307 : 223–227.
  9. Campos PE, Suarez PG, Sanchez J, Zavala D, Arevalo J, Ticona E, Nolan CM, Hooton TM, Holmes KK, 2003. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis 9 : 1571–1578.
  10. Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, Lopez B, Isola N, de Kantor IN, 1997. Nosocomial spread of human immunodeficiency virus-related multi-drug-resistant tuberculosis in Buenos Aires. J Infect Dis 76 : 637–642.
  11. Fischl MA, Uttamchandani RB, Daikos GL, Poblete RB, Moreno JN, Reyes RR, Boota AM, Thompson LM, Cleary TJ, Lai S, 1992. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 117 : 177–183.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.75.1025
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error